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hospitals, but the influence in the community has not been as clearly 
demonstrated. Only with a clear understandmg of all the risk factors 
involved, can effective control measures be introduced. 
The main habitat of the pneumococcus is the nasopharynx of 
chddren and antimicrobial use in chlldren is therefore likely to have 
a significant d u e n c e  on the susceptibility of pneumococci. Re- 
cent studies investigating risk factors for resistance in pneumococci 
have identified antimicrobial use as a risk factor; especially ongo- 
ing, recent, repeated, kequent, and prophylactic use. The effect of 
individual antimicrobial classes has not been studied in detail, but 
use of p-lactam antibiotics and sulpha-trirnethoprim has been asso- 
ciated with increased risk. Day-care centres can facilitate the spread 
of resistant pneumococci, and carriage of resistant pneumococci in 
Iceland was associated with young age, domicile in an area with high 
antimicrobial consumption, recent antimicrobial use, kequent an- 
timicrobial use and use of trimethoprim-sulpha. Other studies have 
also shown a correlation between antimicrobial usage in ditferent 
areas and antimicrobial resistance. 
Reduction of antimicrobial use in Iceland, with subsequent re- 
duced incidence of p e n i c h  resistant pneumococci, may indicate a 
cause and an effect, and should stimulate programs aimed at prudent 
antimicrobial use. 
isolates contain mosaic pbp2x genes where parts are replaced by ho- 
mologous sequences from related species. Mosaic homologues of 
pbp2x are present in penicillin sensitive S. mitis and S. oralis, demon- 
strating that transfer of pbpZx sequences has occurred independent 
on resistance to p e n i c h .  Transfer of pbp2x genes between suscep- 
tible species could indeed be observed under laboratory conditions. 
One class of pbp2x with a high degree of s d a r i t y  to the S. oralis 
pbp2x were found in resistant strains of Merent biovars of S.mitis and 
S. oralis, and major clones of S. pneumoniae from Merent countries 
and even continents. Sequence comparison documents that at least 
another two species participate in the genetic exchange of resistance 
determinants. The data obtained raise the question on the defini- 
tion of species-speclfic sequences for selectable markers in naturally 
transformable bacteria. 
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(s2011 Treatment Options in Resistant Pneumococcal 
Infections 
R. Pallares. Hospital de Bellvifge, University of Barcelona, Spain 
Over the past three decades penicillin-resistant pneumococci 
have emerged worldwide. In addition, penicih-resistant strains 
have also decreased susceptibhty to other be t a - l ace  (including 
cephalosporins) and these strains are often resistant to other antibiotic 
groups, making the treatment options much more ditficult. Never- 
theless, the present in vitro definitions of resistance to penicillin and 
cephalosporins in pneumococci could not be appropriated for all 
types of pneumococcal mfections. Thus, current levels of resistance 
to penicillin and cephalosporin seem to have little, ifany, clinical rel- 
evance in nonmeningeal infections (eg. pneumonia or bacteremia). 
On the contrary, numerous dinical failures have been reported in 
patients with pneumococcal meningitis caused by strains with peni- 
cillin MIC p 0.12 fig/ml, and penicillin should never be used in 
pneumococcal meningitis except when the strain is known to be 
fully susceptible to this drug. Nowadays, therapy for pneumococcal 
meningitis should mainly be selected on the basis of susceptibility 
to cephalosporins, and most patients may currently be treated with 
high dose cefotaxime (f) vancomycin, depending on the levels of 
resistance in the patient’s geographic area. However, it should be em- 
phasized that the most appropriate antibiotic therapy for infections 
caused by resistant pneumococci remains controversial, and compar- 
ative, randomized stumes are urgently needed in order to clarlfy the 
best antibiotic therapy for these infections. We will present a practical 
approach, based on current levels of antibiotic resistance, for treating 
the most prevalent pneumococcal mfections. 
Global epidemiology of the PBP2x gene of 
penicillin-resistant pneumococci 
R. Hakenbeck, A. Konig, P. Reichmann. Mar-Planck Inztitutfut 
Molekulare Genetik, Berlin 
Penicillin-binding proteins (PBPs) functioning as selectable resistance 
determinants can be used to investigate the number of species con- 
tributing to a gene pool that is accessible for a pathogen such as 
Streptococcus pneumoniae. PBP2x is one of the primary penicillin re- 
sistance determinants in S. pneumoniae, and all penich-resistant 
S203 I Bloodborne Pathogens: Update on 
post-exposure management and prophylaxis 
D.M. Bell. Centersfor Disease Confrol and Prevention, Atlanta, G A ,  
U S A  
In 1996, the U.S. Public Health Service recommended post-ex- 
posure prophylaxis (PEP) after certain occupational HIV exposures 
(MMWR 1996); 45: 468-72). This recommendation was based in 
part on a case-control study of health-care workers exposed to HIV 
in the USA and Europe in which zidovudine PEP was associated with 
an approximately 80% reduction in risk of seroconversion (MMWR 
1995; 44: 929-33). CDC has received many inquiries, e.g., concern- 
ing implementation, use ofnewly licensed drugs for PEP, and possible 
use ofPEP for sexual exposures. Periodic updates are expected; a ma- 
jor a c u l t y  is h t e d  data on toxicity and efficacy of PEP. 
For hepatitis C virus (HIV), no PEP is available. Evaluation of 
workers with percutaneous or mucosal exposure to blood from 
source patients positive for anti-HCV might include 6-month fol- 
low-up testing of the exposed worker for anti-HCV and serum 
alanine amino transferase (ALT) activity. All repeatedly reactive tests 
by EL4 should be confirmed by supplemental anti-HCV testing. 
I S204 I The pregnant health-care worker: are special 
A.L. Panlil~o. Centersfor Disease Control and Revention, Atlanta, G4, 
USA 
Immunologic changes that occur during pregnancy generally do not 
increase susceptibility to infectious diseases. Nevertheless, nosoco- 
mul transmission of certain infections may be of particular concern 
to pregnant health-care workers for a variety of reasons. Some infec- 
tions, such as varicella, may be more severe during pregnancy. 
Transplacental infection with viruses such as parvovirus, varicella, 
and rubella has been associated with abomon, congenital anomaly, 
and/or mental retardation. Finally, certain drugs used to treat or 
prevent some infections, e.g., tuberculosis, may be contraindicated 
during pregnancy. Pre-employment screening followed by appropri- 
ate immunizations can prevent many infections in health-care work- 
ers, pregnant or not. Further, careful adherence to infection control 
practices should minimize occupational exposures and nosocomial 
infections in pregnant health-care workers. 
precautions necessary? 
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The Risks for HIV Infected Health Care Worker 
G. Ippolito, N. Petrosillo, V Puro. I R C C S  "L. Spullanzani" Centro 
Rgerimento ADS-Setuizio Epidemiologia MalZatie Injetfive, Roma, Italy 
The Health Care Setting (HCS) is an environment at high risk for 
the transmission ofinfective pathogens. Health care workers ( H C W s )  
are at higher risk of infection in comparison to g e n d  popula- 
tion. Moreover, several nosocomially acquired infections are charac- 
terized by drug resistance (Stuphylococnrs spp., E n t e r o m  spp, My- 
cobactm'um tuberculosis). These facts are of greater concern for those 
HCWs who are immunocompromised because of HIV infection: 
they can have increased susceptibihty to infections as well they can 
develop a more severe clinical course of infectious diseases. Of the 
opportunistic infections, hfethreating for HIV+ persons, Tuberculo- 
sis, Cryptosporidiosis, and Sahnonellosis are those more likely to be 
occupationally acquired. No definitive data are avadable on the sug- 
gested transmission of Pneumocystis curinii via droplets. Other well 
known nosocomial infections such as Pneumococcal disease, In- 
fluenza, HVZ, scabies, can be more severe in HIV+ HCWs. The 
effect of HIV disease progression of the observed enhancement of 
HIV replication, as measured by plasma HIV RNA copies, dur- 
ing infections or after vaccinations is of further concern. Problems 
can arise on scheduling the vaccinations recommended for HCWs. 
HIV+ HCWs must carefully comply with standard and transmission 
based isolation precautions recommended to prevent nosocomial as 
well as occupational infections in HCS. HCWs susceptible to VZV, 
rubeh or measles must be prohibited f b m  providing duect care to 
patients with these infections active. In the case of HIV+ HCWs 
the index of suspicion for occupationally infection should be high. 
A clear policy of restrictions must be planned. 
1 S206 I Varcella Vaccine: Should Healthcare Workers 
T. Vesikari. FIN 
No abstract available. 
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lation. The control of tuberculosis in our cities in inexplicably linked 
with social as well as medical issues. 
I S208 1 Migration and Tuberculoses 
V Schwoebel. European Centre for the Epidemiologiral Monitoring of 
AIDS, Paris, France 
Migration has long influenced the epidemiological patterns of tuber- 
culosis (TB). The importation of the disease to Canada by European 
immigrants, which had devastating effects on the previously unex- 
posed native population, is well documented. 
In 1994, there were 23 million refugees world-wide, most of 
whom migrated in regions of high prevalence of TB infection. Risks 
of TB transmission and TB disease in refugee situations are enhanced 
by overcrowding, stress, malnutrition, and in some settings HIV in- 
fection. The extent of this problem is not fully evaluated and TB 
control in such context is difKcult. 
There are more data on the impact of migration h m  hgh to low 
prevalence countries. In Western Europe, where TB has markedly 
decreased this century, an increasing proportion of cases is found 
among foreign-born persons: over 50% in the Netherlands, Sweden, 
Switzerland. TB incidence rates in immigrants ace usually close to 
those reported in their country of origin, and then decline with time 
since arrival, probably reflecting the likelihood of having become 
infected before arrival. However, poor living conditions or specific 
difKculties in accessing medical care may also contribute to higher 
rates in some groups. 
TB is mostly transmitted to close family contacts, thus the contri- 
bution of TB in migrants to the transmission of TB inside the host 
country is not substantial. DNA fingerprinting studies may improve 
our knowledge of transmission patterns. Tuberculosis elimination in 
Europe requires improving TB control in the migrant population, 
by first ensuring that migrants have prompt and &e access to stan- 
dardised treatment. 
Tuberculosis: Is control under control? 
(Joint Symposium with the International 
Union Against Tuberculosis and Lung 
Disease) 
Tuberculosis in European cities 
J. Moore-Gillon. St. Bartholomew's 6. Royal London Hospituk, 
London, UK 
It is sometimes assumed that TB treatment and control in relatively 
prosperous countries with good healthcare systems is easy by com- 
parison with the problems encountered in developing countries. In 
fact TB in the cities of Europe produces its own major challenges 
and TB rates in some inner city areas are higher than in some parts 
of Afiica. 
Overcrowdmg facditates infection and poverty with its accom- 
panying poor nutrition and prevalence of other diseases facilitates 
the progression to active disease. Multi-ethtllc populations produce 
difficulties of both language and cultural health beliefs. Population 
mobihty and turnover makes treatment supervision and contact trac- 
We must invest adequate medical and public health resources for 
treatment and control of tuberculosis in European cities. Approaches 
to healthcare need to reflect the cultural diversity of each city's popu- 
ing difficult. 
I S209 I Tuberculosis and HIV in the Developing World 
H.L. Rieder. International Union Against Tuberculosis and Lung 
Diseate, Paris, France 
Objectives: To demonstrate the adverse impact of HIV infection on 
the epidemiology of tuberculosis in the developing world. 
Methods: Review of the literature and other reports fkm 
sub-Saharan Akica, h i i n  America, and Asia on HIV and tuber- 
culosis. 
Results: The countries reviewed have a high prevalence of in- 
fection with Mycobartenurn tuberculosis in common. Adults in the age 
groups at particularly high risk of HIV have a prevalence of infection 
with M .  tuberculosis that is much larger than that found in industri- 
alized countries. The extent to which HIV-associated tuberculosis 
contributes to the total tuberculosis burden is thus solely dependent 
on the inroads the HIV epidemic has made. Some countries, par- 
ticularly in sub-Saharan Africa, have recorded exponential in-es 
in the number of tuberculosis cases, and the number of cases is 
rapidly increasing in some other countries in South-Fast Asia and 
in hiin-America. To stem the tide has proved ddlicult, because of 
both lack of resources and structured tuberculosis control pcograms. 
Conclusions: Tuberculosis is far h m  being controlled in many 
resource-poor countries and if decisive action is not taken s d y ,  
the prospects are gloomy for the coming century. 
